fbpx

FDA Adjusts Booster Advice

FDA Adjusts Booster Advice

The FDA is authorizing Pfizer boosters for 12-to-15-year-olds amid a surge in COVID cases, driven by the Omicron variant. 

Sara Lee Kessler with details.

Leave a Reply

Your email address will not be published. Required fields are marked *